GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Costas Inc (OTCPK:CSSI) » Definitions » EV-to-FCF

Costas (Costas) EV-to-FCF : (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Costas EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Costas's Enterprise Value is $13.37 Mil. Costas does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Costas's EV-to-FCF at this moment.

The historical rank and industry rank for Costas's EV-to-FCF or its related term are showing as below:

CSSI's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.85
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), Costas's stock price is $0.03. Costas does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Costas's PE Ratio at this moment.


Costas EV-to-FCF Historical Data

The historical data trend for Costas's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Costas EV-to-FCF Chart

Costas Annual Data
Trend
EV-to-FCF

Costas Quarterly Data
EV-to-FCF

Competitive Comparison of Costas's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Costas's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Costas's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Costas's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Costas's EV-to-FCF falls into.



Costas EV-to-FCF Calculation

Costas's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=13.372/
=


Costas  (OTCPK:CSSI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Costas's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.03/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Costas EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Costas's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Costas (Costas) Business Description

Traded in Other Exchanges
N/A
Address
424 East Central Boulevard, Suite 308, Orlando, FL, USA, 32801
Costas Inc operates in the dental lab industry, is currently manufacturing dental prosthetics for dentists and dental clinics via its first operational lab facility throughout the United States.